Northwestern Mutual Wealth Management
ATYR

Northwestern Mutual Wealth Management’s aTyr Pharma ATYR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-286
Closed -$4K – 2656
2018
Q2 		$4K Buy
+286
New +$6.78K ﹤0.01% 2072

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northwestern Mutual Wealth Management's ATYR Position: Q3 2018 in Review

Northwestern Mutual Wealth Management sold out of aTyr Pharma (ATYR) in Q3 2018, closing a stake of 286 shares — an estimated $4K sold.

Northwestern Mutual Wealth Management first reported a position in ATYR in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 31 funds tracked by Wall St. Rank hold ATYR as of Q3 2018.

  • Northwestern Mutual Wealth Management reported no remaining aTyr Pharma position as of Q3 2018 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 286 aTyr Pharma shares in Q3 2018, an estimated $4K.
  • Northwestern Mutual Wealth Management first reported a position in aTyr Pharma in Q2 2018 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's aTyr Pharma position peaked at $4K in Q2 2018.
  • 31 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2018.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2018, filed 1 Nov 2018.